zphc Retatrutide 20mg (4mg * 5 vial)

ZPHC Retatrutide 20mg (4mg * 5 Vials) for Research

Discover the next generation of metabolic research with Retatrutide 20mg from ZPHC, a leading global name in peptide manufacturing. This advanced compound represents a significant breakthrough in weight management and obesity studies, offering a unique triple-hormone receptor agonist approach that targets GLP-1, GIP, and glucagon receptors simultaneously.

Key Features of ZPHC Retatrutide:

• Triple Action Mechanism: Unlike older generations, Retatrutide stimulates three vital metabolic pathways, optimizing fat browning and appetite regulation clinical models.
• High Purity Standards: Manufactured by ZPHC under strict laboratory guidelines to ensure maximum potency, stable peptide chains, and premium quality.
• Enhanced Metabolic Impact: Developed specifically to study intense fat tissue reduction, caloric control, and glycemic improvements in laboratory environments.

Product Specifications:

• Total Concentration: 20 mg.
• Packaging: 1 box containing 5 vials, with each vial providing 4 mg of lyophilized powder (4mg * 5 vials).
• Form: Lyophilized (freeze-dried) powder. Requires reconstitution with bacteriostatic water before any laboratory use.

Storage and Handling Guidelines:

To preserve the structural integrity of the Retatrutide peptide bonds, store the unconstitutioned vials in a cold, dry place away from direct sunlight. It is highly recommended to keep the product refrigerated between 2°C to 8°C. Once reconstituted with bacteriostatic water, the solution must remain refrigerated at all times and handled with extreme care—avoid shaking the vial violently to prevent degradation of the active compound.

Medical and Legal Disclaimer:

This product is supplied exclusively for in-vitro laboratory research, analytical studies, and scientific testing. It is not intended for human consumption, direct therapeutic use, or medical diagnosis. Please consult qualified medical consensus guidelines and follow professional protocols when handling research peptides. Always verify product safety by inspecting the physical label, dosage values, and packaging details before initializing any research procedures.